At present, neonates are being given screening tests for relatively rare diseases, such as phenylketonuria. The time has come to give emphasis to assessing the risk for major handicapping diseases, such as coronary heart disease, stroke, and certain diseases of the kidney. Modern technology for blood pressure and heart rate monitoring and data analysis provides noninvasive means to determine when preventive measures are indicated.
|Original language||English (US)|
|Number of pages||7|
|Journal||Progress in Clinical and Biological Research|
|State||Published - Jan 1 1987|